Lees M - Search Results

1

Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer.

Lees M, Aristides M, Maniadakis N, McKendrick J, Botwood N, Stephenson D. Lees M, et al. Pharmacoeconomics. 2002;20(5):325-37. doi: 10.2165/00019053-200220050-00004. Pharmacoeconomics. 2002. PMID: 11994042 Clinical Trial.

2

Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK.

Aristides M, Lees M, Botwood N, McKendrick J, Stephenson DA, Maniadakis N. Aristides M, et al. Among authors: lees m. Eur J Health Econ. 2003 Sep;4(3):216-21. doi: 10.1007/s10198-003-0173-6. Epub 2003 Jul 1. Eur J Health Econ. 2003. PMID: 15609188

3

Cost-effectiveness of pergolide compared to bromocriptine in the treatment of Parkinson's disease: a decision-analytic model.

Davey P, Rajan N, Lees M, Aristides M. Davey P, et al. Among authors: lees m. Value Health. 2001 Jul-Aug;4(4):308-15. doi: 10.1046/j.1524-4733.2001.44039.x. Value Health. 2001. PMID: 11705298 Free article.

4

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe.

Schiller J, Tilden D, Aristides M, Lees M, Kielhorn A, Maniadakis N, Bhalla S. Schiller J, et al. Among authors: lees m. Lung Cancer. 2004 Jan;43(1):101-12. doi: 10.1016/j.lungcan.2003.06.003. Lung Cancer. 2004. PMID: 14698544

5

Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B.

Crowley SJ, Tognarini D, Desmond PV, Lees M. Crowley SJ, et al. Among authors: lees m. Pharmacoeconomics. 2000 May;17(5):409-27. doi: 10.2165/00019053-200017050-00001. Pharmacoeconomics. 2000. PMID: 10977384 Clinical Trial.

6

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.

Gibson E, Koblbauer I, Begum N, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M. Gibson E, et al. Among authors: lees m. Pharmacoeconomics. 2017 Dec;35(12):1257-1270. doi: 10.1007/s40273-017-0558-5. Pharmacoeconomics. 2017. PMID: 28866758 Free PMC article.

7

Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.

Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M. Duran A, et al. Among authors: lees m. Pharmacoeconomics. 2012 Feb 1;30(2):87-101. doi: 10.2165/11599370-000000000-00000. Pharmacoeconomics. 2012. PMID: 22187932

8

Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.

Friedman RJ, Sengupta N, Lees M. Friedman RJ, et al. Among authors: lees m. Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):299-306. doi: 10.1586/erp.11.15. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21671699 Review.

9

An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?

Shafrin J, Skornicki M, Brauer M, Villeneuve J, Lees M, Hertel N, Penrod JR, Jansen J. Shafrin J, et al. Among authors: lees m. Health Policy. 2018 Jun;122(6):607-613. doi: 10.1016/j.healthpol.2018.04.008. Epub 2018 Apr 26. Health Policy. 2018. PMID: 29731176 Free article.

10

Cost-effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden.

Ryttberg L, Diamantopoulos A, Forster F, Lees M, Fraschke A, Björholt I. Ryttberg L, et al. Among authors: lees m. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):601-15. doi: 10.1586/erp.11.65. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters